Hydrochloric Acid

Hydrochloric Acid

SCHEMBL608188

Cl.Cl.O=C(O)c1ccc2ccccc2c1C(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA known ✓ P06280 2/20 0.59
GAA known ✓ P10253 1/20 0.46
LDHA P00338 1/20 0.69
WDR5 P61964 1/20 0.66
ALDH1A1 P00352 5/20 0.59
HPGD P15428 4/20 0.59
KDM4E B2RXH2 3/20 0.59
NR4A1 P22736 1/20 0.59
NR4A2 P43354 1/20 0.59
NR4A3 Q92570 1/20 0.59
MEN1 O00255 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2C19 P33261 1/20 0.59
KMT2A Q03164 1/20 0.59
HSD17B10 Q99714 1/20 0.59
CDC25B P30305 2/20 0.56
METAP2 P50579 1/20 0.49
METAP1 P53582 1/20 0.49
LMNA P02545 1/20 0.47
CSNK2A2 P19784 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2383857 1.00 LDHA (0.69) LDHAWDR5ALDH1A1HPGDKDM4E
SCHEMBL33850 0.98 WDR5 (0.68) LDHAWDR5ALDH1A1HPGDKDM4E
Benzene SCHEMBL27549874 0.98 WDR5 (0.68) LDHAWDR5ALDH1A1HPGDKDM4E
SCHEMBL27804512 0.98 WDR5 (0.68) LDHAWDR5ALDH1A1HPGDKDM4E
SCHEMBL29376013 0.98 WDR5 (0.68) LDHAWDR5ALDH1A1HPGDKDM4E
Naphthalene SCHEMBL1831655 0.96 WDR5 (0.66) LDHAWDR5ALDH1A1HPGDKDM4E
Ammonia Solution, Strong SCHEMBL8803959 0.96 WDR5 (0.66) LDHAWDR5ALDH1A1HPGDKDM4E
SCHEMBL964273 0.96 WDR5 (0.66) LDHAWDR5ALDH1A1HPGDKDM4E
SCHEMBL18812861 0.96 WDR5 (0.66) LDHAWDR5ALDH1A1HPGDKDM4E
SCHEMBL4577224 0.96 WDR5 (0.66) LDHAWDR5ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 505 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260054227-A1 COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME H2MO TECH PTE LTD (SG) 2026-02-26 US claimed
US-12485388-B2 Composite membrane and method of making the same H2MO TECHNOLOGY PTE LTD (SG) 2025-12-02 US claimed
CN-119565382-A Method for cleaning reverse osmosis membrane and reverse osmosis membrane prepared by same 万华化学集团股份有限公司 2025-03-07 CN claimed
CN-115845615-B High-flux polyethylene-based reverse osmosis membrane and preparation method and application thereof 万华化学集团股份有限公司 2025-02-18 CN claimed
CN-113766966-B Composite film and method for producing same 南洋理工大学 2024-08-27 CN claimed
CN-114146567-B Preparation process of epoxy modified reverse osmosis membrane, reverse osmosis membrane and application of reverse osmosis membrane 万华化学集团股份有限公司 2024-06-25 CN claimed
CN-114146566-B Preparation method of high-performance polyolefin substrate reverse osmosis membrane, reverse osmosis membrane and application 万华化学集团股份有限公司 2024-05-03 CN claimed
CN-115583834-B High-performance aramid-based graphite film and preparation method thereof 浙江中科玖源新材料有限公司 2024-02-20 CN claimed
US-20230330604-A1 MOLECULARLY POROUS CROSS-LINKED MEMBRANES UNIV KING ABDULLAH SCI & TECH (SA) 2023-10-19 US claimed
CN-112827368-B Anti-pollution reverse osmosis membrane and preparation method thereof 中化(宁波)润沃膜科技有限公司 2023-08-11 CN claimed
CN-112827368-A Anti-pollution reverse osmosis membrane and preparation method thereof 中化(宁波)润沃膜科技有限公司 2021-05-25 CN claimed
CN-111715083-A Modified polyamide desalting layer, reverse osmosis membrane and preparation method and application thereof 万华化学集团股份有限公司 2020-09-29 CN claimed
CN-111632498-A Preparation method of non-woven fabric substrate supported polyethylene nanofiltration membrane 上海恩捷新材料科技有限公司 2020-09-08 CN claimed
US-10730819-B2 Naphthalenedicarboxylic acid dichloride production method KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2020-08-04 US claimed
CN-111039779-A Process for producing naphthalenedicarboxylic dichloride 京瓷办公信息系统株式会社 2020-04-21 CN claimed
US-20200115313-A1 NAPHTHALENEDICARBOXYLIC ACID DICHLORIDE PRODUCTION METHOD KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2020-04-16 US claimed
US-20160263530-A1 FABRICATION AND MODIFICATION OF POLYMER MEMBRANES USING INK-JET PRINTING B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD (IL) 2016-09-15 US claimed
EP-1020218-B1 COMPOSITE REVERSE OSMOSIS MEMBRANE AND PROCESS FOR PREPARING THE SAME NITTO DENKO CORP (JP) 2003-05-21 EP claimed
EP-1020218-A1 COMPOSITE REVERSE OSMOSIS MEMBRANE AND PROCESS FOR PREPARING THE SAME NITTO DENKO CORPORATION (JP) 2000-07-19 EP claimed
US-4617368-A DICARBOXYLIC ACID DICHLORIDE USED AS STARTING MATERIALS PREPARED BY CHLORINATION OF DIMETHYL ESTERS; TERTIARY AMINES AS CATALYSTS BAYER AKTIENGESELLSCHAFT (DE) 1986-10-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115313-A1 NAPHTHALENEDICARBOXYLIC ACID DICHLORIDE PRODUCTION METHOD DDT, DHODH, DLD GLA 1575/4885GAA 2062/4885LDHA 383/4885
US-20260054227-A1 COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME AQP1, AQP4, AQP3 GLA 3275/4885GAA 4174/4885LDHA 3142/4885
US-10730819-B2 Naphthalenedicarboxylic acid dichloride production method DDT, DHODH, DLD GLA 1575/4885GAA 2062/4885LDHA 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.